ATR and posterior cortical atrophy: Given the alterations in DDR genes between WT and P1 LNCaPs, these cells were tested in response to olaparib (PARPi) and ceralasertib (ATR inhibitor), both of which have been shown effective as PCa treatments [46, 47].